from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2560/-

LFCtreatmentdescriptionclass of inhibitor

1.363

Amikacinug/mL Amikacintranslation

2.038

Cap5-10ug/mL Capreomycintranslation

1.943

Rox10-50 ug/mL Roxithromycintranslation

0.374

SM2-5 ug/mL Streptomycintranslation

0.107

Tet5-10 ug/mL Tetracyclinetranslation

-0.015

Rif0.2-5ug/mL Rifampicintranscription

0.322

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.871

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.614

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.679

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.860

Clofazimine10-13 ug/mL Clofaziminerespiration

0.120

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.662

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.676

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.472

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.586

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.088

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.647

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.099

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.692

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.277

KCN5-20 ug/mL Potassium cyaniderespiration

-0.291

NaN30.2-2 mM Sodium aziderespiration

0.891

Nigericin50 uM Nigericinrespiration

-0.480

TRC10-150 ug/mL Triclosanrespiration

-0.613

TRZ10-25 ug/mL Thioridazinerespiration

-1.478

Valinomycin0.5-10 uM Valinomycinrespiration

0.664

ZnSO42 mM ZnSO4respiration

0.131

menadione6-10 ug/mL Menadionerespiration

-0.544

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.648

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.054

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.456

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.049

NRP_1Non-replicating persistence stage 1dosRassociated

0.461

Amp0.2mg/mL AmpicillincellWall

1.000

Cephalexin20-100 ug/mL CephalexincellWall

0.238

Cerulenin0.32-5 ug/mL CerulenincellWall

0.450

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.298

EMB10-20 ug/mL EthambutolcellWall

0.106

Eta12-40 ug/mL EthionamidecellWall

-0.042

INH0.2-0.4 ug/mL IsoniazidcellWall

0.206

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.203

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.221

BZA0.12 mg/mL BenzamidearomaticAmides

-0.365

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.538

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.201

H2O24 mM hydrogen peroxideDNAdamaging

-0.032

Levo10 ug/mL LevofloxacinDNAdamaging

-0.069

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.327

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.058

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.353

UVUV-irradiationDNAdamaging

-1.148

ARP41-4 ug/mL Antitubercular compound ARP4?

0.159

Antimycin12.5-50 ug/mL Antimycin A?

0.953

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

0.470

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.179

PA8240.2-2 ug/mL PA-824?

0.260

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.269

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.481

Verapamil50 uM Verapamil?

0.804

mercaptoethanol2 mM 2-Mercaptoethanol?

0.243

methoxatin10-20 ug/mL Methoxatin?